Evidence map›Paper›PMID 27288568›Full record

ReviewSeminars in cell & developmental biology2016

Ras signaling through RASSF proteins.

Howard Donninger, M Lee Schmidt, Jessica Mezzanotte, Thibaut Barnoud, Geoffrey J Clark

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genetic Variants inGenes · 2025
    Article
  5. BRAT1 - a new therapeutic target for glioblastoma.Cellular and molecular life sciences : CMLS · 2025
    Article
  6. Article
  7. NORE1A loss promotes MASLD/MASH.Transgenic research · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Apoptosis in Type 2 Diabetes: Can It Be Prevented? Hippo Pathway Prospects.International journal of molecular sciences · 2022
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Howard DonningerDepartment of Medicine, University of Louisville, KY, 40202, USA.
M Lee SchmidtDepartment of Pharmacoloxy and Toxicology, University of Louisville, KY, 40202, USA.
Jessica MezzanotteDepartment of Biochemistry and Molecular Genetics, Molecular Targets Program, J.G Brown Cancer Center, University of Louisville, Louisville, KY, 40202, USA.
Thibaut BarnoudDepartment of Biochemistry and Molecular Genetics, Molecular Targets Program, J.G Brown Cancer Center, University of Louisville, Louisville, KY, 40202, USA.
Geoffrey J ClarkDepartment of Pharmacoloxy and Toxicology, University of Louisville, KY, 40202, USA. Electronic address: gjclar01@louisville.edu.
University of Louisville · US

Funding

PROJ 12: STEM CELL-BASED VACCINE FOR CANCER PROPHYLAXISP20RR018733 · NCRR · UNIVERSITY OF LOUISVILLE · PI LI, QIUTANG · 2003 to 2011
$18.9M
The role of the Ras effector Nore1a in tumor suppressionR01CA133171 · NCI · UNIVERSITY OF LOUISVILLE · PI CLARK, GEOFFREY J. · 2010 to 2014
$1.3M
Oncopigs as a better model for human cancerR01CA153132 · NCI · UNIVERSITY OF LOUISVILLE · PI CLARK, GEOFFREY J., RUND, LAURETTA · 2010 to 2013
$1.0M
NCI NIH HHS R01 CA133171NCI NIH HHS R01 CA153132NCRR NIH HHS P20 RR018733
6 · The paper itself

Abstract

There are six core RASSF family proteins that contain conserved Ras Association domains and may serve as Ras effectors. They lack intrinsic enzymatic activity and appear to function as scaffolding and localization molecules. While initially being associated with pro-apoptotic signaling pathways such as Bax and Hippo, it is now clear that they can also connect Ras to a surprisingly broad range of signaling pathways that control senescence, inflammation, autophagy, DNA repair, ubiquitination and protein acetylation. Moreover, they may be able to impact the activation status of pro-mitogenic Ras effector pathways, such as the Raf pathway. The frequent epigenetic inactivation of RASSF genes in human tumors disconnects Ras from pro-death signaling systems, enhancing Ras driven transformation and metastasis. The best characterized members are RASSF1A and RASSF5 (NORE1A).

Indexed as

Signal TransductionAnimalsHumansModels, Biologicalras ProteinsTumor Suppressor Proteinsras ProteinsTumor Suppressor ProteinsApoptosisNORE1Ap53RasRASSF1ASignaling

Identifiers

PMID27288568
PMCPMC5034565
OpenAlexW2409603723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.